Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
HES
Hess
HES
|
+$1.35B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.14B |
| 3 |
Bank of America
BAC
|
+$851M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$393M |
| 5 |
PayPal
PYPL
|
+$375M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$2.23B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.02B |
| 3 |
Walt Disney
DIS
|
+$689M |
| 4 |
Eli Lilly
LLY
|
+$622M |
| 5 |
Meta Platforms (Facebook)
META
|
+$565M |
Sector Composition
| 1 | Technology | 17.03% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 11.64% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLRS
4951
Kalaris Therapeutics, Inc. Common Stock
KLRS
$69.4M
| $110K | ﹤0.01% |
6,357
-4,072
| -39% | -$70.7K |
|
4952
WidePoint Corp
WYY
$53.7M
| $110K | ﹤0.01% |
42,436
+17,138
| +68% | +$44.4K |
|
|
OKUR
4953
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$32.3M
| $110K | ﹤0.01% |
6,615
+5,648
| +584% | +$93.8K |
|
4954
Nuveen Massachusetts Quality Municipal Income Fund
NMT
$109M
| $110K | ﹤0.01% |
+10,041
| New | +$110K |
|
|
CRDL
4955
Cardiol Therapeutics
CRDL
$90.4M
| $109K | ﹤0.01% |
+60,398
| New | +$109K |
|
4956
DoubleVerify
DV
$2.13B
| $109K | ﹤0.01% |
3,109
-294,346
| -99% | -$10.3M |
|
4957
Valens Semiconductor
VLN
$184M
| $109K | ﹤0.01% |
46,516
-18,075
| -28% | -$42.5K |
|
4958
Rocket Pharmaceuticals, Inc. Warrant
RCKTW
$3.96M
| $109K | ﹤0.01% |
364,823
+64,523
| +21% | +$19.3K |
|
|
VIA
4959
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $109K | ﹤0.01% |
+10,057
| New | +$109K |
|
|
ZOM
4960
DELISTED
Zomedica Corp.
ZOM
| $108K | ﹤0.01% |
743,107
-73,490
| -9% | -$10.7K |
|
|
ICAD
4961
DELISTED
iCAD Inc
ICAD
| $108K | ﹤0.01% |
67,054
+18,029
| +37% | +$29K |
|
4962
Neuropace
NPCE
$325M
| $108K | ﹤0.01% |
8,150
-15,905
| -66% | -$210K |
|
4963
Clearside Biomedical
CLSD
$20.7M
| $107K | ﹤0.01% |
70,173
+24,335
| +53% | +$37.2K |
|
|
XNET
4964
Xunlei
XNET
$482M
| $107K | ﹤0.01% |
71,954
-11,964
| -14% | -$17.8K |
|
4965
Direxion Daily FTSE China Bear 3X Shares
YANG
$160M
| $107K | ﹤0.01% |
461
-9,110
| -95% | -$2.12M |
|
4966
Vor Biopharma
VOR
$203M
| $107K | ﹤0.01% |
45,078
+14,432
| +47% | +$34.2K |
|
4967
Global Partners
GLP
$1.71B
| $106K | ﹤0.01% |
+2,393
| New | +$106K |
|
|
IPM
4968
Intelligent Protection Management Corp. Common Stock
IPM
$26.5M
| $106K | ﹤0.01% |
34,451
+11,709
| +51% | +$36.1K |
|
|
GOEV
4969
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $106K | ﹤0.01% |
1,485
+1,090
| +276% | +$77.8K |
|
|
PPTA
4970
Perpetua Resources
PPTA
$1.94B
| $106K | ﹤0.01% |
25,431
+14,244
| +127% | +$59.3K |
|
4971
KALA BIO
KALA
$135M
| $106K | ﹤0.01% |
+13,468
| New | +$106K |
|
4972
Horizon Technology Finance
HRZN
$291M
| $106K | ﹤0.01% |
9,286
+2,559
| +38% | +$29.1K |
|
|
HYB
4973
DELISTED
New America High Income Fund, Inc.
HYB
| $105K | ﹤0.01% |
+14,451
| New | +$105K |
|
4974
Genasys
GNSS
$101M
| $105K | ﹤0.01% |
44,377
-19,025
| -30% | -$45.1K |
|
4975
ON24
ONTF
$233M
| $105K | ﹤0.01% |
14,727
-267,759
| -95% | -$1.91M |
|